Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

A study of over 600,000 U.S. veterans found that GLP-1 drugs like semaglutide are associated with reduced risks of developing substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs. These medications also correlate with fewer overdoses, hospitalizations, emergency visits, and drug-related deaths among individuals already struggling with addiction.